Optimizing treatment guidelines for adrenal diseases using real-world data
Official title: Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data: An Initiative by the Korean Adrenal Disorder Study (KADS) Group
Run by Seoul National University Hospital · NCT06229405 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is trying to find the best treatment guidelines for adrenal diseases by looking at real patient data from different hospitals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 8200 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06229405 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 19 years or older diagnosed with adrenal gland disorders.
✕Probably not a fit
Patients under 19 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to establish clinical evidence for optimal treatment guidelines for adrenal diseases by utilizing real-world data. The study involves creating both prospective and retrospective patient registries for conditions such as primary aldosteronism, pheochromocytoma, and adrenal cancer. By linking these registries with hospital medical records and public data, the research seeks to generate comprehensive clinical evidence that addresses unmet needs in the management of adrenal disorders. The study is conducted across multiple centers, including Seoul National University Hospital and Asan Medical Center.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment guidelines and outcomes for patients with adrenal diseases.
How similar studies have gone: Other studies utilizing real-world data for similar conditions have shown promise, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with adrenal diseases such as adrenal cortical carcinoma, Cushing's syndrome, primary aldosteronism, pheochromocytoma, adrenal incidentaloma * patients who are 19 years or older Exclusion Criteria: * patients younger than 19 years old
Where it's running
-
Seoul National University Hospital
Seoul, Korea, Republic of Recruiting
Study contacts
- Principal investigator: Jung Hee Kim, MD, PhD — Seoul National University Hospital
- Study coordinator: Jung Hee Kim, MD, PhD
- Email: jhee1@snu.ac.kr
- Phone: +82-10-2072-4839
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for Rare Diseases
This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.
-
Comparing recovery after adrenal surgery with and without drainage tubes
This study is testing whether having surgery for adrenal problems without drainage tubes helps patients recover faster and feel less pain compared to traditional surgery with tubes.
-
Investigating adrenal tumors and their treatments
This study looks at adrenal tumors and their treatments to see how they develop and what therapies might help patients feel better.
-
Kidney stiffness measured by ultrasound in hypertension and healthy volunteers
This study tests whether kidney stiffness measured by a non-invasive ultrasound method differs between people with high blood pressure and healthy individuals.
-
Inclisiran vs. Statin for Primary Aldosteronism
This trial tests whether inclisiran plus amlodipine works differently from a statin-based approach in people with primary aldosteronism and high blood pressure.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.